Westerkirk Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.85M Sell
6,253
-1,147
-16% -$341K 0.2% 87
2025
Q4
$2.02M Buy
7,400
+300
+4% +$81.5K 0.2% 82
2025
Q3
$1.92M Hold
7,100
0.22% 85
2025
Q2
$1.96M Buy
+7,100
New +$1.93M 0.24% 86

Other funds holding CME

Westerkirk Capital's CME Position: Q1 2026 in Review

Westerkirk Capital reduced its CME Group (CME) stake by 16% in Q1 2026, selling an estimated $341K and leaving 6,253 shares worth $1.85M. The position accounts for 0.2% of the portfolio, ranked #87.

Westerkirk Capital first reported a position in CME in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.02M in Q4 2025. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Westerkirk Capital held 6,253 shares of CME Group worth $1.85M as of Q1 2026.
  • Westerkirk Capital sold 1,147 CME Group shares in Q1 2026, an estimated $341K.
  • CME Group made up 0.2% of Westerkirk Capital's portfolio in Q1 2026, its #87 holding.
  • Westerkirk Capital first reported a position in CME Group in Q2 2025 and has held it in 4 quarters since.
  • Westerkirk Capital's CME Group position peaked at $2.02M in Q4 2025.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Westerkirk Capital's 13F filing for Q1 2026, filed 14 May 2026.